Patients with mutations in tafazzin (TAZ), the enzyme that modulates levels of mitochondrial membrane-specific lipid cardiolipin, also show symptoms like ataxia, cardiomyopathy, and 3MGA [115]. This evidence concerns the gene TAFAZZIN and Ataxia.